Opinion

Video

Understanding Mechanisms of Action: Ruxolitinib, Ibrutinib, and Belumosudil

Dr. Merin describes the mechanisms of action of ruxolitinib, ibrutinib, and belumosudil and shares clinical pearls for community oncologists on methods for achieving response with these agents.

Video Player is loading.
Current Time 0:00
Duration 7:06
Loaded: 0%
Stream Type LIVE
Remaining Time 7:06
 
1x
  • Chapters
  • descriptions off, selected
  • captions off, selected
  • en (Main), selected
Related Content